Right Turn: This is not a One Direction concert review

Author: Stacey Johnson, 08/21/15

Harry_Styles_November_2014.

Last night, I took my daughters to a One Direction concert. Regardless of what you might now think of me (us), they still have several (million) fans around the world. The 40,000 screaming girls in attendance at the Rogers Centre showed the Brit boys lots of love.

Anyhoo, earlier this week I was trying to decide what to blog about and, just for fun, I Googled One Direction and stem cells. A little to my surprise, a relevant hit came up: “One Direction’s Harry Styles gets bizarre beauty treatment….”

Yes, the looker with the long brown locks gets sheep placenta facials, but they call them stem cell facials for clients who are “more squeamish than Harry,” says medical aesthetician Louise Deschamps from Dr. Lancer Dermatology in Beverly Hills. This is all according to Life and Style magazine. Apparently he has the facials to keep his skin looking “really fresh.” I’m pretty sure he could rub anything on his face and the 21-year-old would still look young. Because he’s 21!

Hunky Harry’s treatments cost $800 for a 90-minute session and he’s not the only celebrity who imbibes.

Who can blame the companies offering these treatments? Product demand in the “cosmeceutical” industry is estimated to be nearly US$50 billion by 2018. The U.S. market is currently $9+ billion and is expected to reach $11.5 billion by 2017. Approximately 65 percent of the U.S. market is skin care, of which ~55 percent is age-defying products.[1]

People are living longer, but they still want to stay young looking. The cosmeceutical industry is composed of around 400 companies around the world and 80 per cent of these manufacture skin care products. The largest companies in the world for finished skin care cosmeceuticals include Johnson & Johnson, Proctor & Gamble, L’Oreal, Avon, Allergan and Estee Lauder. [2]

L’Oreal is perhaps the most well-known cosmetics company to enter the regenerative medicine field, through its partnership with Organovo, to produce 3D printed skin. Shiseido, another cosmetics giant, is working with Vancouver-based RepliCel to commercialize a hair regenerative treatment for those who have pattern baldness or thinning hair.

I don’t think it’s a stretch to assume we’ll see more of these types of partnerships as new regenerative medicine technologies catch the attention of beauty companies, with deep pockets, wanting to capture a growing market and differentiate their products from their competitors.

This market is heading in One Direction and I think it’s up.

No_Control_-_One_DirectionOur regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.

As always, we welcome your feedback in the comment section.

[1] Brandt FS, Cazzaniga A, & Hann M. “Cosmeceuticals: Current Trends and Market Analysis.” Semin Cutan Med Surg 30:141-143, 2011

[2] Market research conducted by CCRM’s business development team.

The following two tabs change content below.
Stacey Johnson

Stacey Johnson

For almost 20 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. Prior to that, Stacey was at the CTV Television Network, first as a researcher, then as a story producer for “Goldhawk Fights Back,” a special ombudsman segment that aired weekly on the National News and Canada AM. Before joining CCRM as the Director, Communications and Marketing, Stacey was the Director of Communications for the Canadian Arthritis Network. Stacey is editor of Signals. You can follow Stacey on Twitter @msstaceyerin.
Stacey Johnson

Latest posts by Stacey Johnson (see all)

Tags: , , , , , , , , , ,

Leave a Reply

*
*